Roivant Sciences ROIV Income Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $3.35M-76.2% | $4.14M-76.9% | $6.37M-68.7% | $10.29M-51.2% | $14.07M-36.1% | ||
| $178.11M-31.1% | $191.55M-20.3% | $210.14M-2.3% | $234.57M+28.9% | $258.38M+76.5% | ||
| $4.01M+137% | -$11.4M+40.6% | -$22.56M-58.2% | -$18.32M-27.7% | -$10.72M-74.6% | ||
| —— | $143.87M— | $100.96M— | $20.84M— | $55.19M— | ||
| —— | -$809.24M-2,446% | -$373.97M-108% | -$490.63M-110% | -$171.98M-104% | ||
| $1.29M+41.1% | $1.17M+29.7% | $729K-13.2% | $852K+2.8% | $911K-81.1% | ||
| $3.77M— | —— | —— | —— | —— | ||
| $0-100% | $0-100% | $112K-91.4% | $445K-68.5% | $774K-50.0% | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $110.39M-97.9% | ||
| $3.42M— | -$12.9M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$2.39M+58.2% | -$2.35M+69.2% | -$3.58M+53.0% | -$4.36M+46.4% | -$5.7M+31.5% | ||
| -$11.46M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $770.24M— | $577.68M— | $385.12M— | $192.56M— | $0— | ||
| —— | —— | —— | -$746.95M-246% | -$1.22B-370% | ||
| —— | —— | —— | —— | —— | ||
| -$750.35M+10.6% | -$759.1M+2.1% | -$769.86M+1.1% | -$851.01M-20.2% | -$839.45M-9.7% | ||
| $8.28M+20.9% | $8.38M+25.7% | $7.57M+13.1% | $7.21M+5.9% | $6.84M0.0% | ||
| —— | —— | -$33.18M-548% | -$9.27M+56.8% | -$3.76M+63.3% | ||
| —— | —— | —— | $853.14M+31.6% | $1.29B— | ||
| —— | —— | $14.52M+445% | $7.67M+294% | $4.6M+233% | ||
| $268.35M+441% | $229.76M+470% | $139.06M+560% | $77.38M+118% | $49.6M-8.7% | ||
| $346.17M+19.8% | $352.48M+39.7% | $331.17M+48.6% | $321.02M+60.1% | $289.03M+44.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Roivant Sciences's revenue?
- Roivant Sciences (ROIV) generated $8.3M in revenue over the trailing twelve months, down 71.6% year over year.
- Where does Roivant Sciences's income statement data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
